Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...

Heart attack care is entering a phase where machines do not just assist doctors, they anticipate the next move. A new ...

Abbott today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volttm PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin commercial ...

Abbott’s Volt pulsed field ablation system — for the treatment of atrial fibrillation. The Volt system delivers high-energy electrical pulses to targeted areas of the heart to disrupt abnormal rhythms ...

Abbott has announced the company has received approval from the U.S. Food and Drug Administration (FDA) for its Volt PFA ...

After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an | With the U.

Abbott (NYSE: ABT) announced today that the FDA approved its Volt pulsed field ablation (PFA) system to treat patients with AFib.

US FDA approves Abbott's Volt PFA System to treat patients with atrial fibrillation: Abbott Park, Illinois Wednesday, December 24, 2025, 12:00 Hrs [IST] Abbott, is a global health ...

I felt fine, but my Whoop data told a different story. Paying attention led to early detection and a successful treatment.

Columbus Regional Health Electrophysiology team completes 500th ablation case for treating irregular heartbeats ...

Summary • Adagio Medical Holdings, Inc. (ADGM) saw a 19.3% increase in stock price, reaching $1.30 during intraday trading.• The surge followed the appointment of Marie-Claude Jacques and Antwan ...